Evidence map›Paper›PMID 32954047›Full record

ArticleGene reports2020

Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.

Abdullah Shah, Farooq Rashid, Abdul Aziz, Amin Ullah Jan, Muhammad Suleman

Abstract read
In one paragraph

Article in Gene reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.Biochemical and biophysical research communications · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Abdullah ShahDepartment of Biotechnology, Shaheed Benazir Bhutto University Sheringal, Dir, Pakistan.
Farooq RashidSchool of Public Health, Department of Epidemiology, Southern Medical University, Dermatology Hospital, Guangzhou, China.
Abdul AzizMolecular Biology Research Center, School of Life Sciences, Central South University, Changsha, China.
Amin Ullah JanDepartment of Biotechnology, Shaheed Benazir Bhutto University Sheringal, Dir, Pakistan.
Muhammad SulemanCentre for Biotechnology and Microbiology, University of Swat, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since December 2019, a severe pandemic of pneumonia, COVID-19 associated with a novel coronavirus (SARS-CoV-2), have emerged in Wuhan, China and spreading throughout the world. As RNA viruses have a high mutation rate therefore we wanted to identify whether this virus is also prone to mutations. For this reason we selected four major structural (Spike protein (S), Envelope protein (E), Membrane glycoprotein (M), Nucleocapsid phosphoprotein (N)) and ORF8 protein of 100 different SARS-CoV-2 isolates of fifteen countries from NCBI database and compared these to the reference sequence, Wuhan NC_045512.2, which was the first isolate of SARS-CoV-2 that was sequenced. By multiple sequence alignment of amino acids, we observed substitutions and deletion in S protein at 13 different sites in the isolates of five countries (China, USA, Finland, India and Australia) as compared to the reference sequence. Similarly, alignment of N protein revealed substitutions at three different sites in isolates of China, Spain and Japan. M protein exhibits substitution only in one isolates from USA, however, no mutation was observed in E protein of any isolate. Interestingly, in ORF8 substitution of Leucine, a nonpolar to Serine a polar amino acid at same position (aa84 L to S) in 23 isolates of five countries i.e. China, USA, Spain, Taiwan and India were observed, which may affect the conformation of peptides. Thus, we observed several mutations in the isolates thereafter the first sequencing of SARS-CoV-2 isolate, NC_045512.2, which suggested that this virus might be a threat to the whole world and therefore further studies are needed to characterize how these mutations in different proteins affect the functionality and pathogenesis of SARS-CoV-2.

Indexed as

angiotensin converting enzyme 2, ACE2coronavirus disease of 2019, COVID-19COVID-2envelope protein, Emembrane glycoprotein, MMutationName, Abbreviationsnonstructual proteins, NSPsnucleocapsid phosphoprotein, Nopen reading frame, ORFPhosphorylationSARS-CoV-2Serine/Threonine kinasesSevere Acute Respiratory Syndrome-Coronavirus-2, SARS-CoV-2surface glycoprotein, SWorld Health Organization, WHO

Identifiers

PMID32954047
PMCPMC7487737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.